Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis

NCT00854087 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

118

Enrollment

INDIV

Sponsor class

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG: Fuzheng Huayu
DRUG: Placebo

Sponsor

Tarek Hassanein

Collaborators

[object Object]